<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Twenty-one <z:hpo ids='HP_0004808'>acute myeloid leukemia</z:hpo> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">AML</z:e>) patients were enrolled and received oral induction therapy with <z:chebi fb="0" ids="28680">cytarabine</z:chebi> ocfosfate (SPAC) and <z:chebi fb="0" ids="4911">etoposide</z:chebi> (EP) </plain></SENT>
<SENT sid="1" pm="."><plain>The median age was 69 years (range: 33-86) </plain></SENT>
<SENT sid="2" pm="."><plain>There were 11 patients with de novo <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">AML</z:e> and 10 AML cases that had evolved from <z:hpo ids='HP_0002863'>myelodysplastic syndromes</z:hpo> </plain></SENT>
<SENT sid="3" pm="."><plain>Seventeen patients had abnormal karyotypes including eight complex abnormalities, various complications, and 7 of 21 had a poor performance status (PS) with Eastern Cooperative <z:hpo ids='HP_0002664'>Oncology</z:hpo> Group (ECOG) scores of 3-4 </plain></SENT>
<SENT sid="4" pm="."><plain><z:hpo ids='HP_0000001'>All</z:hpo> patients completed induction therapy without severe adverse events </plain></SENT>
<SENT sid="5" pm="."><plain>Seven achieved complete remission (CR), and two achieved partial remission (PR) </plain></SENT>
<SENT sid="6" pm="."><plain>Uni- and multivariate analyses demonstrated a positive and significant correlation between the results of therapy (CR +/- PR) and overall survival </plain></SENT>
<SENT sid="7" pm="."><plain>The plasma concentrations of <z:chebi fb="1" ids="16040">cytosine</z:chebi> <z:chebi fb="0" ids="22601">arabinoside</z:chebi> (ara-C) in some cases were higher than those previously reported, indicating the accumulation of ara-C with increasing numbers of days of SPAC administration </plain></SENT>
<SENT sid="8" pm="."><plain>We conclude that this therapy is well tolerated and useful for refractory and elderly <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">AML</z:e> patients </plain></SENT>
</text></document>